Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$13.38 - $18.8 $182,744 - $256,770
-13,658 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$17.08 - $29.6 $77,082 - $133,584
-4,513 Reduced 24.84%
13,658 $240,000
Q1 2021

May 06, 2021

SELL
$5.86 - $27.73 $68,421 - $323,775
-11,676 Reduced 39.12%
18,171 $458,000
Q4 2020

Feb 09, 2021

BUY
$2.65 - $7.61 $79,094 - $227,135
29,847 New
29,847 $193,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.